Phosphoinositide 3-kinase in Health and Disease
Volume 1
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress. Here the authors give a brief overview of some key discoveries in the PI3K area and their impact, and include thoughts on the current state of the field, and where it could go from here.
CHF 259.50
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Vogt, Peter K. (Hrsg.) / Rommel, Christian (Hrsg.)
- ISBN: 978-3-642-13663-4
- EAN: 9783642136634
- Produktnummer: 13911758
- Verlag: Springer
- Sprache: Englisch
- Erscheinungsjahr: 2010
- Seitenangabe: 310 S.
- Plattform: PDF
- Masse: 4'581 KB
5 weitere Werke von Bart (Hrsg.) Vanhaesebroeck:
Bewertungen
Anmelden